Related Experiment Video
Updated: Jul 23, 2025

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
Can't drop the MIC(A/B): Preventing stress-ligand shedding to enhance pan-cancer targeting
Nora Lakes1, Laura M Canaday2, Stephen N Waggoner3
1Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA; Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Abstract:
Chimeric antigen receptor (CAR)-based cellular therapies have achieved remarkable success against hematologic malignancies, but their application against solid tumors remains challenging. In this issue, Goulding et al.1 describe a unique CAR natural killer (NK) cell platform with pan-cancer activity via preservation and recognition of stress ligands on tumor cell membranes.

